DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Noxafil (Posaconazole) - Adverse Event Reports - Serious Event - Aspergillosis

 



Index of reports > Cases resulting in a serious event (63) > Cases with Aspergillosis (5)

Below is the selection of adverse event reports related to Noxafil (Posaconazole) that includes cases resulting in a serious event where reactions include aspergillosis.

Adverse event in 7 year old male receiving Noxafil (Posaconazole)

Reported by a pharmacist from United States on 2007-04-18

Patient: 7 year old male, weighing 28.0 kg (61.6 pounds)

Adverse reactions / side effects: Disease Recurrence, Aspergillosis, Condition Aggravated, Pancreatitis, Pulmonary Mass

Adverse event resulted in: hospitalization

Suspect drug(s):
Noxafil
    Dosage: see image
    Administration route: Oral
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2007-03-11
    End date: 2007-03-11

Noxafil
    Dosage: see image
    Administration route: Oral
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2007-03-15
    End date: 2007-03-16

Noxafil
    Dosage: see image
    Administration route: Oral
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2007-03-17
    End date: 2007-03-25

Noxafil
    Dosage: see image
    Administration route: Oral
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2007-03-26

Other drugs received by patient: Meropenem (Con); Voriconazole (Prev)



Adverse event in 7 year old male receiving Noxafil (Posaconazole)

Reported by a pharmacist from United States on 2007-03-28

Patient: 7 year old male

Adverse reactions / side effects: Aspergillosis, Pulmonary Mass, Lipase Increased

Suspect drug(s):
Noxafil (Posaconazole)



Adverse event in 19 year old male receiving Noxafil (Posaconazole)

Reported by a physician from Germany on 2007-03-14

Patient: 19 year old male

Adverse reactions / side effects: Staphylococcal Infection, Abscess Fungal, Nephropathy Toxic, Aspergillosis, Renal Abscess, Catheter Site Infection, Renal Failure Acute

Suspect drug(s):
Noxafil
    Dosage: 400 mg; bid; po
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2006-09-28
    End date: 2006-11-26

Ambisome
    Dosage: 200 mg; qd
    Indication: Aspergillosis
    Start date: 2006-11-07
    End date: 2006-11-25

Other drugs received by patient: Voriconazole; Steroids; Caspofungin



Adverse event in 19 year old male receiving Noxafil (Posaconazole)

Reported by a physician from Germany on 2007-02-26

Patient: 19 year old male

Adverse reactions / side effects: Staphylococcal Infection, Aspergillosis, Catheter Site Infection, Renal Failure Acute

Suspect drug(s):
Noxafil
    Dosage: 400 mg; bid; po
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2006-09-28
    End date: 2006-11-26

Ambisome
    Dosage: 200 mg; qd; iv
    Indication: Aspergillosis
    Start date: 2006-11-07
    End date: 2006-11-25

Other drugs received by patient: Voriconazole; Steroids; Caspofungin; Amphotericin B



Adverse event in 19 year old male receiving Noxafil (Posaconazole)

Reported by a health professional (non-physician/pharmacist) from Germany on 2007-01-26

Patient: 19 year old male

Adverse reactions / side effects: Drug Toxicity, Staphylococcal Infection, Aspergillosis, Renal Abscess, Catheter Site Infection, Renal Failure Acute

Suspect drug(s):
Noxafil
    Dosage: 400 mg;bid;po
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2006-09-28
    End date: 2006-11-26

Ambisome
    Dosage: 200 mg;qd;iv
    Indication: Aspergillosis
    Start date: 2006-11-07
    End date: 2006-11-25

Other drugs received by patient: Voriconazole; Steroids; Caspofungin

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009